Gilead Sciences collaborates with Indian partners for antiretroviral therapy
11:37 EDT 3 Aug 2012 | Current Partnering
Gilead Sciences, together with Mylan Laboratories, Ranbaxy Laboratories Limited and Strides Arcolab, have entered into agreements to collaborate on promoting access to high-quality, low-cost generic versions of Gilead’s HIV medicine emtricitabine in developing countries – including single tablet regimens containing emtricitabine, and fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines. Under the new [...]The post Gilead Sciences collaborates with Indian par..
Original Article: Gilead Sciences collaborates with Indian partners for antiretroviral therapy
More From BioPortfolio on "Gilead Sciences collaborates with Indian partners for antiretroviral therapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
